TDZD-8

CAS No. 327036-89-5

TDZD-8( TDZD 8 | TDZD8 | GSK-3β Inhibitor I | NP 01139 )

Catalog No. M14061 CAS No. 327036-89-5

A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 48 In Stock
25MG 69 In Stock
50MG 113 In Stock
100MG 178 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TDZD-8
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM).
  • Description
    A potent, selective, non-ATP competitive GSK-3β inhibitor with IC50 of 2 uM; displays no activity against PKA, CK-2, PKC, and CDK1 (IC50>100 uM); reduces the colonic inflammation induced by TNBS in vivo, also prevents 6-OHDA-induced neuronal cell death.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TDZD 8 | TDZD8 | GSK-3β Inhibitor I | NP 01139
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3β
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    327036-89-5
  • Formula Weight
    222.2636
  • Molecular Formula
    C10H10N2O2S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(N1CC2=CC=CC=C2)N(C)SC1=O
  • Chemical Name
    1,2,4-Thiadiazolidine-3,5-dione, 2-methyl-4-(phenylmethyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Martinez A, et al. J Med Chem. 2002 Mar 14;45(6):1292-9. 2. Whittle BJ, et al. Br J Pharmacol. 2006 Mar;147(5):575-82. 3. Dugo L, et al. Crit Care Med. 2005 Sep;33(9):1903-12.
molnova catalog
related products
  • IM-12

    IM-12 is a novel potent GSK-3β inhibitor with IC50 of 53 nM, significantly increases the β-catenin level and activates canonical Wnt signalling.

  • AZD1080

    AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively.

  • GSK-3 Inhibitor 5

    GSK-3 Inhibitor 5 (4-Cyanophenacyl bromide) is a ketone derivative that is used as an intermediate in pharmaceuticals and organic synthesis, and inhibits glycogen synthase kinase 3 (GSK-3).